MFDX - ETF AI Analysis
Top Page
PIMCO RAFI Dynamic Multi-Factor International Equity ETF (MFDX)
Rating:64Neutral
Price Target:―
Positive Factors
Broad Country Diversification
The fund spreads its investments across many countries, which helps reduce the impact if any single market struggles.
Mix of Sectors
Holdings are spread across a wide range of sectors, so the ETF is not overly tied to the fortunes of just one industry.
Generally Strong Recent Performance
The ETF has shown solid gains so far this year and over recent months, suggesting its strategy has been working in the current market.
Negative Factors
Moderately High Expense Ratio
The fund’s fees are higher than many low-cost index ETFs, which can slowly eat into long-term returns.
Exposure to Some Weak Top Holdings
A few of the largest positions have been weak performers this year, which can drag on overall results if the trend continues.
Heavy Tilt Toward Japan and Europe
A large share of the portfolio is concentrated in Japan and several European markets, which may hurt performance if those regions lag the global economy.
MFDX vs. SPDR S&P 500 ETF (SPY)
AUM440.64M
RegionDeveloped Markets
Expense Ratio0.39%
Beta0.64
IssuerPIMCO
Inception DateAug 31, 2017
Dividend Yield2.82%
Asset ClassEquity
Index TrackedRAFI Dynamic Multi-Factor Developed Ex-U.S. Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume23,552
30 Day Avg. Volume27,517
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
46.73Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1281
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MFDX Summary
MFDX is the PIMCO RAFI Dynamic Multi-Factor International Equity ETF. It tracks the RAFI Dynamic Multi-Factor Developed Ex-U.S. Index, which means it invests in many large and mid-sized companies outside the United States. The fund spreads money across countries like Japan, the UK, and Europe, and across many sectors, including industrials, finance, and consumer companies. Well-known holdings include Novartis and Nestlé. Someone might invest in MFDX to diversify beyond U.S. stocks and seek long-term growth from global markets. A key risk is that international stock prices can go up and down with global market and currency swings.
How much will it cost me?The PIMCO RAFI Dynamic Multi-Factor International Equity ETF (MFDX) has an expense ratio of 0.39%, which means you’ll pay $3.90 per year for every $1,000 invested. This is slightly higher than average for ETFs because it uses an actively managed multi-factor strategy to adjust its portfolio dynamically, aiming to optimize performance and reduce risk.
What would affect this ETF?MFDX’s focus on developed international markets and multi-factor investing could benefit from global economic growth, particularly in sectors like Financials and Industrials, which are heavily weighted in the fund. However, challenges such as rising interest rates, geopolitical tensions, or regulatory changes in key regions could negatively impact its performance, especially for top holdings like banks or consumer-focused companies. Diversification across sectors and countries helps mitigate risks but does not eliminate them entirely.
MFDX Top 10 Holdings
MFDX is leaning on a mix of European heavyweights, with chip-equipment star ASML and energy name ENI doing much of the heavy lifting thanks to their strong, recently rising share prices. Utilities player Engie and telecom operator Orange are also pulling their weight, adding a steady defensive backbone. On the flip side, consumer staple giant Nestlé and pharma leader Roche have been more sluggish, slightly braking the fund’s momentum. Overall, the ETF is broadly diversified across sectors and is firmly anchored in developed markets outside the U.S., especially Europe.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Novartis AG | 0.86% | $3.74M | CHF207.57B | 22.14% | 80 Outperform | |
| Banco Santander | 0.84% | $3.65M | €149.64B | 62.09% | 73 Outperform | |
| ASML Holding NV | 0.79% | $3.40M | €477.33B | 106.32% | 76 Outperform | |
| ENI S.p.A. | 0.77% | $3.35M | €67.12B | 80.46% | 63 Neutral | |
| Engie SA | 0.76% | $3.29M | €71.51B | 60.99% | 64 Neutral | |
| Roche Holding AG | 0.75% | $3.25M | $327.04B | 22.13% | 73 Outperform | |
| Nestlé SA | 0.72% | $3.14M | CHF205.30B | -1.29% | 71 Outperform | |
| Glencore | 0.71% | $3.09M | £65.21B | 107.72% | 68 Neutral | |
| Societe Generale | 0.70% | $3.04M | €44.77B | 63.30% | 72 Outperform | |
| Tokyo Electron | 0.66% | $2.85M | ¥21.01T | 103.22% | 73 Outperform |
MFDX Technical Analysis
Positive
―
Price Trends
40.72
Positive
40.13
Positive
38.15
Positive
Market Momentum
0.23
Positive
55.49
Neutral
49.82
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For MFDX, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 41.39, equal to the 50-day MA of 40.72, and equal to the 200-day MA of 38.15, indicating a bullish trend. The MACD of 0.23 indicates Positive momentum. The RSI at 55.49 is Neutral, neither overbought nor oversold. The STOCH value of 49.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MFDX.
MFDX Peer Comparison
Comparison Results
Performance Comparison
MFDX
PIMCO RAFI Dynamic Multi-Factor International Equity ETF
41.48
8.64
26.31%
SEIE
SEI Select International Equity ETF
―
―
―
IMFL
Invesco International Developed Dynamic Multifactor ETF
―
―
―
IDHQ
Invesco S&P International Developed High Quality ETF
―
―
―
TLTD
FlexShares Morningstar Developed Markets ex-US Factor Tilt
―
―
―
FYLD
Cambria Foreign Shareholder Yield ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents